FStar Therapeutics Performance
The firm shows a Beta (market volatility) of 0.0, which means not very significant fluctuations relative to the market. the returns on MARKET and FStar Therapeutics are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days FStar Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, FStar Therapeutics is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 18.5 M | |
| Total Cashflows From Investing Activities | -643 K |
FStar |
FStar Therapeutics Relative Risk vs. Return Landscape
If you would invest (100.00) in FStar Therapeutics on October 19, 2025 and sell it today you would earn a total of 100.00 from holding FStar Therapeutics or generate -100.0% return on investment over 90 days. FStar Therapeutics is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than FStar, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
FStar Therapeutics Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for FStar Therapeutics' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as FStar Therapeutics, and traders can use it to determine the average amount a FStar Therapeutics' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| FSTX |
Based on monthly moving average FStar Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of FStar Therapeutics by adding FStar Therapeutics to a well-diversified portfolio.
FStar Therapeutics Fundamentals Growth
FStar Stock prices reflect investors' perceptions of the future prospects and financial health of FStar Therapeutics, and FStar Therapeutics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on FStar Stock performance.
| Return On Equity | -0.61 | |||
| Return On Asset | -0.22 | |||
| Profit Margin | (2.11) % | |||
| Operating Margin | (1.62) % | |||
| Current Valuation | 98.23 M | |||
| Shares Outstanding | 21.98 M | |||
| Price To Book | 2.13 X | |||
| Price To Sales | 5.47 X | |||
| Revenue | 21.17 M | |||
| EBITDA | (30.17 M) | |||
| Cash And Equivalents | 35.57 M | |||
| Cash Per Share | 1.62 X | |||
| Total Debt | 9.61 M | |||
| Debt To Equity | 0.22 % | |||
| Book Value Per Share | 2.59 X | |||
| Cash Flow From Operations | (27.27 M) | |||
| Earnings Per Share | (1.83) X | |||
| Total Asset | 123.02 M | |||
Things to note about FStar Therapeutics performance evaluation
Checking the ongoing alerts about FStar Therapeutics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for FStar Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| FStar Therapeutics is not yet fully synchronised with the market data | |
| FStar Therapeutics has some characteristics of a very speculative penny stock | |
| FStar Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 21.17 M. Net Loss for the year was (31.28 M) with profit before overhead, payroll, taxes, and interest of 21.17 M. | |
| FStar Therapeutics currently holds about 35.57 M in cash with (27.27 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.62. |
- Analyzing FStar Therapeutics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether FStar Therapeutics' stock is overvalued or undervalued compared to its peers.
- Examining FStar Therapeutics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating FStar Therapeutics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of FStar Therapeutics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of FStar Therapeutics' stock. These opinions can provide insight into FStar Therapeutics' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Consideration for investing in FStar Stock
If you are still planning to invest in FStar Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the FStar Therapeutics' history and understand the potential risks before investing.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |